triazoles has been researched along with Hyperinsulinism in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, MM; Blackburn, BK; Haus, JM; Mahmoud, AM; Mey, JT; Miranda, ER; Phillips, SA | 1 |
Anvar, AR; Hernández-Carretero, A; Rivera, AJ; Skarra, DV; Thackray, VG | 1 |
Drucker, DJ; Duez, H; Giacca, A; Lewis, GF; Smith, AC; Szeto, L; Xiao, C | 1 |
Butler, AE; Butler, PC; Cox, HI; Dry, S; Galasso, R; Gurlo, T; Matveyenko, AV; Moshtaghian, A | 1 |
Allister, EM; Bhattacharjee, A; Wheeler, MB | 1 |
Grimault, A; Lyoen, M; Minello, A; Rostain, F; Sgro, C | 1 |
6 other study(ies) available for triazoles and Hyperinsulinism
Article | Year |
---|---|
Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function.
Topics: Adult; Arterioles; Benzoxazoles; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hyperinsulinism; Insulin; Muscle, Skeletal; NADPH Oxidase 2; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Triazoles; Vasodilation | 2017 |
Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.
Topics: Animals; Eating; Energy Metabolism; Female; Glucose; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Letrozole; Mice; Mice, Inbred C57BL; Nitriles; Obesity; Sexual Maturation; Triazoles; Weight Gain | 2017 |
Acute dipeptidyl peptidase-4 inhibition rapidly enhances insulin-mediated suppression of endogenous glucose production in mice.
Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucose Clamp Technique; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.
Topics: Amyloid; Animals; Animals, Genetically Modified; Arginine; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose Clamp Technique; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Islet Amyloid Polypeptide; Islets of Langerhans; Metformin; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles | 2009 |
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Hyperinsulinism; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Obese; Phenylalanine; Triazoles | 2012 |
VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
Topics: Antifungal Agents; Aspergillosis; Enterocolitis; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Syncope; Treatment Outcome; Triazoles; Voriconazole | 2013 |